Group B Streptococcus Tapp biological GBS nucleic acid detection kit

Exclusive in China and leading in technology; Independent research and development, patented technology; High sensitivity and specificity; Simple, rapid and reproducible;

Close the pipeline to avoid pollution.

Prevention and treatment of GBS infection

The prevention of GBS infection mainly focuses on eliminating the GBS carrier status of mothers and babies (drug prevention) or giving protective immunity to newborns (active/passive). There are not many strains causing GBS infection in perinatal period, so it is undoubtedly an economical and effective means to develop vaccines. In addition, it can also reduce the use of antibiotics, thus reducing the occurrence of GBS drug resistance.

At present, it has been reported abroad that women who are pregnant for 32-34 weeks are vaccinated with specific GBS vaccine to produce IgG antibodies, which proves that 90% of mothers' neonatal infection and postpartum GBS infection can be prevented.